The FDA has announced a nationwide recall of a seafood product manufactured by New Hoque & Sons Inc. in Maspeth, NY, due to serious health risks associated with uneviscerated fish. The recalled product, known as “Dry Ghoinnya Fish,” was found to contain internal organs, which poses a significant risk of botulism. This situation marks a critical violation of health regulations and could lead to severe illness among consumers.
The New York State Department of Agriculture and Markets conducted routine inspections that discovered the improperly processed fish during sampling. Their findings revealed that the internal organs had not been removed, contrary to state regulations that prohibit the sale of uneviscerated fish. According to the FDA, the sale of such products is banned because the viscera can harbor Clostridium botulinum spores, which are more likely to lead to botulism.
Details of the Recall
The recalled “Dry Ghoinnya Fish” comes in packages weighing between 10 and 12 pounds, sealed in clear plastic. Each package bears an expiration date of May 19, 2025, stamped on its bottom, and the product UPC is 908172635412. The product was distributed across retail stores nationwide, raising concerns for consumers who may have purchased it.
As of now, no illnesses have been reported in connection with this recall. However, health officials emphasize the importance of immediate action. Symptoms of botulism can include dizziness, blurred or double vision, difficulty speaking or swallowing, and, in severe cases, difficulty breathing. Consumers who experience any of these symptoms are advised to seek medical attention without delay.
Consumer Guidance and Next Steps
In light of the recall, consumers who have purchased the “Dry Ghoinnya Fish” are urged to return the product to the place of purchase for a full refund. The FDA has provided a contact number for inquiries: (718) 391-0992. This incident has raised concerns among New York residents, with many expressing anxiety over the presence of warning notices about the fish.
The FDA continues to monitor the situation and work with state health officials to mitigate any potential risks associated with this product. Consumers are encouraged to stay informed and heed any further announcements regarding the safety of their food products.
